Loading...
Market
Story
Illumina to Spin Off Grail in June, Retains 14.5 Percent Stake
Jun 3, 2024, 11:05 PM
Illumina Inc. has officially announced the spin-off of its cancer test subsidiary, Grail. The board of directors approved the spin-off, marking the end of a nearly four-year-long saga. As part of the divestment, Illumina will issue Grail shares to its investors while retaining a 14.5 percent stake in the company. Additionally, the board declared a spin-off dividend of Grail shares. The spin-off is set to be completed in June.
View original story
Similar markets
North America • 20%
Europe • 20%
Asia • 20%
South America • 20%
Australia • 20%
Europe • 25%
Asia • 25%
South America • 25%
Africa • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other regions • 25%
Asia • 25%
Europe • 25%
South America • 25%
No expansion • 25%
Europe • 25%
North America • 25%
Asia-Pacific • 25%
Other Regions • 25%
North America • 25%
Europe • 25%
Asia • 25%
No expansion • 25%
Greater China • 25%
Americas • 25%
Europe • 25%
Rest of Asia Pacific • 25%
Asia-Pacific • 25%
Europe • 25%
North America • 25%
Middle East • 25%
Establishes in North America • 25%
Establishes in Europe • 25%
Establishes in both regions • 25%
Does not establish in any new region • 25%
North America • 25%
Asia • 25%
South America • 25%
Africa • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Global (more than two regions) • 25%